Sixth Department of Neurosurgery, Brain Center Affiliated Hospital of Logistics University of People's Armed Police Force Tianjin China.
Division of Clinical Medicine Chongqing Medical University Chongqing China.
Brain Behav. 2018 Mar 25;8(5):e00907. doi: 10.1002/brb3.907. eCollection 2018 May.
Decompressive craniectomy is widely used for treating patients with traumatic brain injury (TBI). Usually patients have dura mater defect due to surgery or injury itself. The defective area may left open or repaired by artificial dura substitutes. A variety of artificial dura substitutes have been used for this purpose.
This study aimed to evaluate bovine-derived pericardium membrane as artificial dural material for patients with decompressive craniectomy.
Totally 387 patients with severe TBI in our hospital were included in this study. Among them, 192 patients were treated with standard decompressive craniectomy without dura repair (control group). One hundred and ninety-five TBI patients were treated with dura repair by artificial dura materials (ADM). Nonlyophilized bovine pericardium membranes were used as artificial dura material. The postoperative complications were compared in both groups, including infection, seizure, and cerebrospinal fluid (CSF) leakage.
Patients in control group have higher complication rates than patients in ADM group, including subcutaneous hematoma (13.02% in control vs. 4.01% in ADM group, = .004), infection (12.5% in control vs. 5.64% in ADM group, = .021), CSF leakage (13.02% in control vs. 5.13% in ADM group, = .012), and seizure (10.42% in control vs. 3.08% in ADM group, = .007). Patients in ADM group are only associated with higher incidence of foreign body reaction (6 of 195 patients in ADM vs. none from control group).
Bovine-derived pericardium membranes are successfully used as artificial dural substitutes for decompressive craniectomy. Patients with ADM have better clinical outcome than control group.
去骨瓣减压术广泛用于治疗创伤性脑损伤(TBI)患者。通常,由于手术或损伤本身,患者的硬脑膜有缺陷。该缺损区域可能保持开放或用人工硬脑膜替代物修复。已经使用了多种人工硬脑膜替代物来达到这一目的。
本研究旨在评估牛源性心包膜作为去骨瓣减压术患者的人工硬脑膜材料。
本研究共纳入我院 387 例严重 TBI 患者。其中,192 例患者接受标准去骨瓣减压术但未行硬脑膜修补(对照组)。195 例 TBI 患者接受人工硬脑膜材料(ADM)修补硬脑膜。使用非冻干牛心包膜作为人工硬脑膜材料。比较两组患者的术后并发症,包括感染、癫痫发作和脑脊液(CSF)漏。
对照组患者的并发症发生率高于 ADM 组,包括皮下血肿(对照组 13.02% vs. ADM 组 4.01%,=0.004)、感染(对照组 12.5% vs. ADM 组 5.64%,=0.021)、CSF 漏(对照组 13.02% vs. ADM 组 5.13%,=0.012)和癫痫发作(对照组 10.42% vs. ADM 组 3.08%,=0.007)。ADM 组患者仅与更高的异物反应发生率相关(ADM 组 195 例患者中有 6 例 vs. 对照组患者无)。
牛源性心包膜成功地用作去骨瓣减压术的人工硬脑膜替代品。ADM 组患者的临床结局优于对照组。